124 related articles for article (PubMed ID: 14570549)
1. Changes in dopaminergic neurotransmission do not alter somatic or motivational opiate withdrawal-induced symptoms in rats.
Caillé S; Rodriguez-Arias M; Minarro J; Espejo EF; Cador M; Stinus L
Behav Neurosci; 2003 Oct; 117(5):995-1005. PubMed ID: 14570549
[TBL] [Abstract][Full Text] [Related]
2. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome.
Harris GC; Aston-Jones G
Nature; 1994 Sep; 371(6493):155-7. PubMed ID: 7915401
[TBL] [Abstract][Full Text] [Related]
3. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
4. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
7. Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist.
Walters CL; Aston-Jones G; Druhan JP
Neuropsychopharmacology; 2000 Sep; 23(3):307-15. PubMed ID: 10942854
[TBL] [Abstract][Full Text] [Related]
8. Persistent and reversible morphine withdrawal-induced morphological changes in the nucleus accumbens.
Diana M; Spiga S; Acquas E
Ann N Y Acad Sci; 2006 Aug; 1074():446-57. PubMed ID: 17105943
[TBL] [Abstract][Full Text] [Related]
9. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
Caillé S; Espejo EF; Koob GF; Stinus L
Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
[TBL] [Abstract][Full Text] [Related]
10. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.
Schulteis G; Markou A; Gold LH; Stinus L; Koob GF
J Pharmacol Exp Ther; 1994 Dec; 271(3):1391-8. PubMed ID: 7996451
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.
Harris GC; Aston-Jones G
Neuropsychopharmacology; 1993 Dec; 9(4):303-11. PubMed ID: 7905738
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
13. Double dissociation in the neural substrates of acute opiate dependence as measured by withdrawal-potentiated startle.
Harris AC; Atkinson DM; Aase DM; Gewirtz JC
Neuroscience; 2006; 139(4):1201-10. PubMed ID: 16600512
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
Caillé S; Stinus L; Espejo EF; De Deurwaerdère P; Spampinato U; Koob GF
Neuropsychopharmacology; 2003 Feb; 28(2):276-83. PubMed ID: 12589380
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.
Fujio M; Nakagawa T; Sekiya Y; Ozawa T; Suzuki Y; Minami M; Satoh M; Kaneko S
Eur J Neurosci; 2005 Dec; 22(11):2744-54. PubMed ID: 16324108
[TBL] [Abstract][Full Text] [Related]
16. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
[TBL] [Abstract][Full Text] [Related]
17. Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates.
Espejo EF; Serrano MI; Caillé S; Stinus L
Neuropsychopharmacology; 2001 Aug; 25(2):204-12. PubMed ID: 11425504
[TBL] [Abstract][Full Text] [Related]
18. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
19. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
20. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal.
Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R
Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
